Par Drugs And Chemicals Limited has informed the Exchange regarding Appointment of Ms SIDDHPURA And Co as Other of the company w.e.f. April 01, 2025.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals held a board meeting on August 29, 2025, approving its 26th Annual General Meeting for September 27, 2025 in Vadodara. The board approved the re-appointment of Chairman & Managing Director Falgun Vallabhbhai Savani (retiring by rotation) and Independent Director Mrs. Bintal Bhaveshkumar Shah for a second 5-year term starting September 28, 2025. It fixed Rs. 24 lakh per annum remuneration for Independent Director Pravin Manjibhai Bhayani. The board appointed Sarupria Somani & Associates as statutory auditor for FY26 (Rs. 2.25 lakh fees), re-appointed Siddhpura & Co as internal auditor, re-appointed DG Patel & Associates as secretarial auditor for five years (FY26–FY30), and appointed Maulin Shah & Associates as cost auditor (Rs. 60,000 remuneration). The board also approved buying a Tata Harrier SUV worth about Rs. 29.30 lakh for use by Director & CEO Jignesh V. Savani.
These are routine governance and compliance items — auditor and director re-appointments are standard annual processes and unlikely to move the stock. Shareholders should note the AGM date (September 27, 2025), the e-voting window (September 23–26, 2025), and the vehicle purchase for the CEO, which is a small discretionary spend.